🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xiaofeng Wu

Pfizer (United States)

ORCID: 0000-0002-8961-2163
Biochemistry, Genetics and Molecular BiologyMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: CRISPR-Cas9-based mutagenesis frequently provokes on-target mRNA misregulation.

232 citations

Yunku Yeu, John Tyler Piazza, Zhen Tan, Jean Rene Clemenceau, Xiaofeng Wu +9 more

15 citations

Xiaofeng Wu, Andrew Lemoff, Sivaramakrishna Yadavalli, Jeon Lee, Chensu Wang +7 more

108 citations

Kyungsuk Choi, Ting Su, Bing Li, Xiaofeng Wu, Ruihui Zhang +8 more

16 citations

Xiaofeng Wu, Ruoyu Zhang, Chuan‐Chih Hsu, Zhong-Yin Zhang, W. Andy Tao +1 more

3 citations

Anton Iliuk, W. Andy Tao, Xiaofeng Wu

2 citations

Li Li, Kananart Kuwaranancharoen, Xiaofeng Wu, Zheng-Chi Lee, Roy N. Alcalay +4 more

44 citations

Li Li, Kananart Kuwaranancharoen, Xiaofeng Wu, Zheng-Chi Lee, Roy N. Alcalay +4 more

N/A
0DataRank · unranked
23 citations

Yi‐Kai Liu, Anton Iliuk, W. Andy Tao, Xiaofeng Wu

14 citations

Xiaofeng Wu, Marco Hadisurya, Li Li, Hristos Z. Kaimakliotis, Anton Iliuk +2 more

6 citations

Menchus Quan, Marco Hadisurya, Jianzhong Hu, Yi‐Kai Liu, Yuxin Zhuang +6 more